Psychiatry and Neurology, Neurology · Boca Raton, FL
NPI
1851451256
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
660 Glades Road, Suite 220
Boca Raton, FL, 33431
Phone (561) 750-9881
Groups this clinician bills Medicare through
Medicare paid, 2024
$410K
3,106 services
Medicare patients, 2024
1,883
Average age 78
Drug cost, 2024
$2.8M
2,573 prescriptions
Company payments, 2025
$129
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Natalio J Chediak was code 99214 (office e&m - established), 1,989 times for 1,573 patients. In total Natalio J Chediak billed 3,106 services in 8 codes, and Medicare paid $410K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-02-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,989 | 1,573 | $97.74 | $194K |
| 99213 Office E&M - Established | Office | 514 | 426 | $70.16 | $36K |
| 99204 Office E&M - New | Office | 286 | 286 | $127.18 | $36K |
| 95811 Sleep Study | Office | 160 | 158 | $504.78 | $81K |
| 95810 Sleep Study | Office | 124 | 123 | $486.71 | $60K |
| 99203 Office E&M - New | Office | 21 | 21 | $86.44 | $1,815 |
| 95806 Sleep Study | Office | 11 | 11 | $34.25 | $377 |
By year: 2022 $418K for 3,151 services; 2023 $418K for 3,195 services; 2024 $410K for 3,106 services.
Medicare prescription drug claims, 2024
In 2024, the drug Natalio J Chediak prescribed most often to Medicare patients was Trazodone Hcl, with 352 prescriptions and refills. In total Natalio J Chediak wrote 2,573 Medicare prescriptions that cost $2.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trazodone Hcl Generic | 352 | 720 | 80 | $5,486 |
| Clonazepam Generic | 295 | 377 | 50 | $2,679 |
| Temazepam Generic | 237 | 332 | 43 | $3,616 |
| Zolpidem Tartrate Generic | 232 | 376 | 55 | $2,894 |
| Alprazolam Generic | 219 | 295 | 42 | $1,427 |
| Pramipexole Dihydrochloride Pramipexole Di-Hcl | 104 | 277 | 28 | $2,699 |
| Gabapentin Generic | 91 | 149 | 24 | $995 |
| Xyrem Sodium Oxybate | 78 | 78 | Under 11 | $1.1M |
| Sodium Oxybate Generic | 73 | 73 | Under 11 | $970K |
| Eszopiclone Generic | 73 | 130 | 20 | $1,391 |
| Modafinil Generic | 62 | 92 | 13 | $2,287 |
| Armodafinil Generic | 62 | 94 | 16 | $2,895 |
| Quetiapine Fumarate Generic | 58 | 106 | 13 | $2,347 |
| Lorazepam Generic | 53 | 72 | 11 | $604 |
| Dextroamphetamine-Amphetamine Dextroamphetamine/Amphetamine | 52 | 60 | Under 11 | $4,363 |
Brand drugs: 236 claims; generic drugs: 2,337 claims; opioid claims: 55.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Natalio J Chediak $129 ($129 in general payments such as food, travel and fees) from 2 companies. The largest payer was Jazz Pharmaceuticals Inc. with $99.99.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.